Last Posted: Jun-17-2019 11AM
Last Posted: Jun 14, 2019
- Advances in the Treatment of Sickle Cell Disease.
Kapoor Sargam et al. Mayo Clinic proceedings 2018 93(12) 1810-1824 - Wilson disease-treatment perspectives.
Litwin Tomasz et al. Annals of translational medicine 2019 Apr 7(Suppl 2) S68 - Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene Therapies.
Gavan Sean P et al. Journal of personalized medicine 2019 May 9(2) - How to discuss gene therapy for haemophilia? A patient and physician perspective.
Miesbach Wolfgang et al. Haemophilia : the official journal of the World Federation of Hemophilia 2019 May - New molecular therapies for the treatment of hearing loss.
Ma Yutian et al. Pharmacology & therapeutics 2019 May - At $2.1 Million, New Gene Therapy Is The Most Expensive Drug Ever
R Stein, NPR, May 24, 2019 - Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.
Paquin Ryan S et al. Orphanet journal of rare diseases 2019 May 14(1) 102 - Getting serious about the challenge of regulating germline gene therapy.
Caplan Arthur et al. PLoS biology 2019 Apr 17(4) e3000223 - Inherited Platelet Disorders: A Modern Approach to Evaluation and Treatment.
Lambert Michele P et al. Hematology/oncology clinics of North America 2019 Jun 33(3) 471-487 - A Genetics Learning Program for Nurses Caring for Children Treated With Ex Vivo Autologous Gene Therapy.
Williams Lucinda et al. Journal of continuing education in nursing 2019 May 50(5) 218-227
.jpeg)
No hay comentarios:
Publicar un comentario